Orphan Trial leads to First Therapeutic for the Treatment for aTTP
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for rare and orphan diseases, extends its congratulations to Ablynx, a Sanofi company, for its launch of Cablivi® in the German market for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP). OCTOBER 30, 2018 Houston, Oct. 30, 2018 – Pharm-Olam, a global, midsized CRO offering full-service clinical […]
Pharm-Olam Unifies Data on Medidata Cloud, Eliminating Silos
Medidata announced that Pharm-Olam signed a five-year enterprise agreement. Pharm-Olam will leverage a full suite of solutions from Medidata Cloud to bring new efficiencies to both operational processes and study execution to power digital transformation for global sponsors. OCTOBER 24, 2018 CRO accelerates the delivery of life-changing therapies with a single view of data for all […]
Pharm-Olam Supports Clinical Trials and Sponsors Compliance with GDPR
Pharm-Olam LLC aids Pharmaceutical and Biotechs to understand how GDPR affects clinical trials by providing data protection services and GDPR consulting. JULY 31, 2018 Houston, July 31, 2018 – Pharm-Olam International, a global, full-service contract research organization (CRO) specializing in oncology, infectious diseases and vaccines, rare and orphan diseases, provides multiple resources for life science organizations to comply […]
Webinar: GDPR Implementation Across Global Clinical Trial Industry
Webinar by Pharm-Olam, LLC discussing the implementation of GDPR across the global clinical trial industry. APRIL 27, 2018 HOUSTON, Tx. — April 26, 2018. Pharm-Olam International, a global, full-service Contract Research Organization (CRO) specializing in Oncology, Infectious Diseases & Vaccines, Rare Diseases and Pediatric indications, is prepared for the implementation of the European Union’s (EU’s) General Data […]
Pharm-Olam LLC Appoints Dr. Kelly McKee as Chief Medical Officer
Pharm-Olam announced the appointment of Kelly T. McKee, Jr., M.D., M.P.H. as Chief Medical Officer (CMO). JANUARY 11, 2018 Pharm-Olam International, a multinational, full-service Clinical Research Organization (CRO) specializing in Oncology, Infectious Diseases, Rare Diseases and Pediatric indications, today announced the appointment of Kelly T. McKee, Jr., M.D., M.P.H. as Chief Medical Officer (CMO). “Dr. […]